Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Florinda Di Piazza"'
Autor:
Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Marisante Napolitano, Florinda Di Piazza, Antonio Russo, Sergio Mario Siragusa
Publikováno v:
Drugs in Context, Vol 8, Pp 1-4 (2019)
Externí odkaz:
https://doaj.org/article/987b099963f548ba81feb01f5c35fcee
Autor:
Salvatrice Mancuso, Vincenzo Accurso, Marco Santoro, Simona Raso, Angelo Davide Contrino, Alessandro Perez, Florinda Di Piazza, Ada Maria Florena, Antonio Russo, Sergio Siragusa
Publikováno v:
Advances in Hematology, Vol 2020 (2020)
Essential thrombocythemia is a rare hematological malignancy with good overall survival, but moderate to high risk of developing arterial or venous thrombosis lifelong. Different thrombotic risk scores for patients with essential thrombocythemia have
Externí odkaz:
https://doaj.org/article/a8040fdf1f9b4b18b89d514b561cde4d
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL
Autor:
Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Angelo Davide Contrino, Paolo Casimio, Mariano Sardo, Simona Raso, Florinda Di Piazza, Alessandro Perez, Marco Bono, Antonio Russo, Sergio Siragusa
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 12, Iss 1 (2020)
Abstract Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to determine the thrombotic event, including the interaction between platelets,
Externí odkaz:
https://doaj.org/article/ee0f15aa667547ed89c6929f8718e284
Autor:
Vincenzo Accurso, Marco Santoro, Simona Raso, Angelo Davide Contrino, Paolo Casimiro, Florinda Di Piazza, Alessandro Perez, Antonio Russo, Sergio Siragusa
Publikováno v:
Hematology Reports, Vol 11, Iss 4 (2019)
Splenomegaly is one of the major clinical manifestations of primary myelofibrosis and is common also in other chronic Philadelphia-negative myeloproliferative neoplasms, causing symptoms and signs and affecting quality of life of patients diagnosed w
Externí odkaz:
https://doaj.org/article/4d6ee256346148dabe43cd1d2e146c9c
Autor:
Daniele Fanale, Giuseppe Bronte, Francesco Passiglia, Valentina Calò, Marta Castiglia, Florinda Di Piazza, Nadia Barraco, Antonina Cangemi, Maria Teresa Catarella, Lavinia Insalaco, Angela Listì, Rossella Maragliano, Daniela Massihnia, Alessandro Perez, Francesca Toia, Giuseppe Cicero, Viviana Bazan
Publikováno v:
Analytical Cellular Pathology, Vol 2015 (2015)
Microtubules are dynamic and structural cellular components involved in several cell functions, including cell shape, motility, and intracellular trafficking. In proliferating cells, they are essential components in the division process through the f
Externí odkaz:
https://doaj.org/article/47c45085936e40deaa758844f374d87f
Autor:
Salvatrice Mancuso, Marco Santoro, Vincenzo Accurso, Antonio Russo, Marco Bono, Sergio Siragusa, Florinda Di Piazza, Simona Raso, Alessandro Perez, Giuseppe Agliastro
Publikováno v:
Oncology Research and Treatment. 43:526-530
Background/Aims: Cardiovascular risk factors are not considered in the current scores for evaluation of the thrombotic risk in myeloproliferative neoplasms, and in polycythemia vera (PV) in particular. Cytoreduction is currently not indicated in low-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a416a061737732c431e495114ad2835e
https://doi.org/10.1159/000509376
https://doi.org/10.1159/000509376
Autor:
Antonio Russo, Marisante Napolitano, Florinda Di Piazza, Salvatrice Mancuso, Vincenzo Accurso, Sergio Siragusa, Marco Santoro
Publikováno v:
Drugs in Context, Vol 8, Pp 1-4 (2019)
Drugs in Context
Drugs in Context
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm in which clonal proliferation of hematopoietic stem cells and bone marrow fibrosis coexist.1 Patients may eventually die due to leukemic progression, which occurs in up to 20% of cases, or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86802b058d36d554f9be2a17b2eeffb6
https://drugsincontext.com/efficacy-of-ruxolitinib-retreatment-in-a-patient-with-high-risk-myelofibrosis-using-the-international-prognostic-scoring-system
https://drugsincontext.com/efficacy-of-ruxolitinib-retreatment-in-a-patient-with-high-risk-myelofibrosis-using-the-international-prognostic-scoring-system
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL
Autor:
Florinda Di Piazza, Antonio Russo, Angelo Davide Contrino, Simona Raso, Mariano Sardo, Marco Bono, Paolo Casimiro, Salvatrice Mancuso, Sergio Siragusa, Alessandro Perez, Marco Santoro, Vincenzo Accurso
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 12, Iss 1 (2020)
Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean Journal of Hematology and Infectious Diseases
Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc71fa222e725572e8c062ea738f69f
http://mjhid.org/index.php/mjhid/article/view/4061
http://mjhid.org/index.php/mjhid/article/view/4061
Autor:
Ada Maria Florena, Florinda Di Piazza, Simona Raso, Alessandro Perez, Antonio Russo, Angelo Davide Contrino, Salvatrice Mancuso, Sergio Siragusa, Marco Santoro, Vincenzo Accurso
Publikováno v:
Advances in Hematology
Advances in Hematology, Vol 2020 (2020)
Advances in Hematology, Vol 2020 (2020)
Essential thrombocythemia is a rare hematological malignancy with good overall survival, but moderate to high risk of developing arterial or venous thrombosis lifelong. Different thrombotic risk scores for patients with essential thrombocythemia have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b52636a79e70295d5f10291f1d6c202
Autor:
Alessandro Perez, Simona Raso, Paolo Casimiro, Angelo Davide Contrino, Antonio Russo, Vincenzo Accurso, Florinda Di Piazza, Marco Santoro, Sergio Siragusa
Publikováno v:
Hematology Reports; Volume 11; Issue 4; Pages: 8281
Hematology Reports
Hematology Reports, Vol 11, Iss 4 (2019)
Hematology Reports
Hematology Reports, Vol 11, Iss 4 (2019)
Splenomegaly is one of the major clinical manifestations of primary myelofibrosis and is common also in other chronic Philadelphia-negative myeloproliferative neoplasms, causing symptoms and signs and affecting quality of life of patients diagnosed w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d5ffc7704c59ed9fd92850bff058ea7